Osteogenic growth factors

Osteogenic growth factors are a diverse group of signaling proteins, including BMP-2, IGF-1, TGF-β, PDGF, VEGF, and FGF-2, that drive bone formation by stimulating mesenchymal stem cells and stromal cells to differentiate into osteoblasts. They activate key pathways such as BMP/SMAD/RUNX2 and Wnt/β-catenin, upregulating markers like alkaline phosphatase, RUNX2, osteocalcin, and collagen type I to promote proliferation, matrix mineralization, bone regeneration. In disease contexts, these factors play critical roles in fracture healing, osteoporosis treatment, and repairing bone defects, often delivered via scaffolds, hydrogels, or autologous matrices like concentrated growth factor (CGF). Therapeutics like recombinant BMP-2 enhance osteogenesis but require precise spatiotemporal control to mitigate risks such as ectopic bone growth. Emerging applications combine them with stem cells or nano-delivery systems for improved tissue engineering outcomes in skeletal disorders. Overall, they represent promising targets for regenerative medicine, though their pleiotropic effects demand optimized delivery strategies.

Other names

bone growth factorsosteoinductive factorsbone regenerative growth factors

Binding to cell surface receptors to activate signaling cascades (e.g., BMP2/SMAD5/RUNX2 pathway for osteogenesis; Wnt/β-catenin pathway), Promotion of mesenchymal stem cell differentiation into osteoblasts, Upregulation of osteogenic markers (RUNX2, ALP, OCN, COL1A1), Enhanced matrix mineralization and ALP activity